Plasma-activated water (PAW) is receiving much attention in biomedical applications because of its reported potent bactericidal properties. Reactive oxygen and nitrogen species (RONS) that are generated in water upon plasma exposure are thought to be the key components in PAW that destroy bacterial and cancer cells. In addition to developing applications for PAW, it is also necessary to better understand the RONS chemistry in PAW in order to tailor PAW to achieve a specific biological response. With this in mind, we previously developed a UV–vis spectroscopy method using an automated curve fitting routine to quantify the changes in H ₂ O ₂ , NO ₂ ⁻ , NO ₃ ⁻ (the major long-lived RONS in PAW), and O ₂ concentrations. A major advantage of UV–vis is that it can take multiple measurements during plasma activation. We used the UV–vis procedure to accurately quantify the changes in the concentrations of these RONS and O ₂ in PAW. However, we have not yet provided an in-depth commentary of how we perform the curve fitting procedure or its implications. Therefore, in this study, we provide greater detail of how we use the curve fitting routine to derive the RONS and O ₂ concentrations in PAW. PAW was generated by treatment with a helium plasma jet. In addition, we employ UV–vis to study how the plasma jet exposure time and treatment distance affect the RONS chemistry and amount of O ₂ dissolved in PAW. We show that the plasma jet exposure time principally affects the total RONS concentration, but not the relative ratios of RONS, whereas the treatment distance affects both the total RONS concentration and the relative RONS concentrations.

Cold atmospheric plasmas have attracted significant worldwide attention for their potential beneficial effects in cancer therapy. In order to further improve the effectiveness of plasma in cancer therapy, it is important to understand the generation and transport of plasma reactive species into tissue fluids, tissues and cells, and moreover the rates and depths of delivery, particularly across physical barriers such as skin. In this study, helium (He) plasma jet treatment of a 3D cancer tumour, grown on the back of a live mouse, induced apoptosis within the tumour to a depth of 2.8 mm. The He plasma jet was shown to deliver reactive oxygen species through the unbroken skin barrier before penetrating through the entire depth of the tumour. The depth and rate of transport of He plasma jet generated H ₂ O ₂ , NO ₃ ⁻ and NO ₂ ⁻ , as well as aqueous oxygen [O ₂ (aq)], was then tracked in an agarose tissue model. This provided an approximation of the H ₂ O ₂ , NO ₃ ⁻ , NO ₂ ⁻ and O ₂ (aq) concentrations that might have been generated during the He plasma jet treatment of the 3D tumour. It is proposed that the He plasma jet can induce apoptosis within a tumour by the ‘deep’ delivery of H ₂ O ₂ , NO ₃ ⁻ and NO ₂ ⁻ coupled with O ₂ (aq); the latter raising oxygen tension in hypoxic tissue.

To investigate the potential role of the hydroxyl radical (^•OH) in cold atmospheric plasma (CAP) jet treatment, two fluorescence-based methodologies are utilised to measure DNA strand breaks. The first comprises a model system of a double-stranded DNA oligomer, where the respective strand ends are tagged with fluorophore and quencher molecules; and the second, a cell culture system reporting DNA strand breaks using the γ-H2AX assay. During the various CAP jet treatments, optical emission spectroscopy is used to detect the ^•OH in the gas phase and electron spin resonance is used to detect the ^•OH in solution. The CAP jet production of the ^•OH is shown to correlate to CAP jet induced DNA damage both with the DNA model and in biological cells. Results indicate that the CAP jet induces a higher degree of DNA damage when the CAP plume is in contact with the target solution. The potential of a ‘plasma screen’ based upon a hydrogel film, as a method to remove the DNA-damaging ^•OH species from reaching skin cells, is shown to significantly reduce DNA damage whilst facilitating the delivery of hydrogen peroxide. These findings could aid in the development of CAP jet-based applications where DNA damage is the objective (e.g. in cancer treatment) and others where it is to be avoided, e.g. in open-wound treatment and dermatology.

We employed UV–vis spectroscopy to monitor real-time changes in the oxygen tension and concentration of reactive oxygen and nitrogen species (RONS) in deionized (DI) water during treatments with helium (He) and argon (Ar) gas plasma jets. He and Ar gas jets are both shown to de-oxygenate DI water with He being more efficient than Ar, whilst the plasma jets deliver and regulate the concentrations of hydrogen peroxide (H ₂ O ₂ ), nitrite (NO ₂ ⁻ ) and nitrate (NO ₃ ⁻ ) in DI water. The H ₂ O ₂ and NO ₃ ⁻ production efficiency varied between He and Ar plasma jets, but was similar for NO ₂ ⁻ . Whilst DI water fully equilibrated with ambient air prior to treatment (de-oxygenated by both plasma jets) when DI water was first de-oxygenated by an inert gas jet treatment, both plasma jets were found to be capable of oxygenating DI water. These insights were then used to show how different combinations of plasma jet and inert gas jet treatments can be used to modulate O ₂ tension and RONS chemistry. Finally, potential further improvements to improve control in the use of plasma jets in regulating O ₂ and RONS are discussed.

The mechanisms of plasma in medicine are broadly attributed to plasma-derived reactive oxygen and nitrogen species (RONS). In order to exert any intracellular effects, these plasma-derived RONS must first traverse a major barrier in the cell membrane. The cell membrane lipid composition, and thereby the magnitude of this barrier, is highly variable between cells depending on type and state (e.g. it is widely accepted that healthy and cancerous cells have different membrane lipid compositions). In this study, we investigate how plasma-derived RONS interactions with lipid membrane components can potentially be exploited in the future for treatment of diseases. We couple phospholipid vesicle experiments, used as simple cell models, with molecular dynamics (MD) simulations of the lipid membrane to provide new insights into how the interplay between phospholipids and cholesterol may influence the response of healthy and diseased cell membranes to plasma-derived RONS. We focus on the (i) lipid tail saturation degree, (ii) lipid head group type, and (iii) membrane cholesterol fraction. Using encapsulated molecular probes, we study the influence of the above membrane components on the ingress of RONS into the vesicles, and subsequent DNA damage. Our results indicate that all of the above membrane components can enhance or suppress RONS uptake, depending on their relative concentration within the membrane. Further, we show that higher RONS uptake into the vesicles does not always correlate with increased DNA damage, which is attributed to ROS reactivity and lifetime. The MD simulations indicate the multifactorial chemical and physical processes at play, including (i) lipid oxidation, (ii) lipid packing, and (iii) lipid rafts formation. The methods and findings presented here provide a platform of knowledge that could be leveraged in the development of therapies relying on the action of plasma, in which the cell membrane and oxidative stress response in cells is targeted.